Home » Teva Sees Limited Competition in Biosimilar Market
Teva Sees Limited Competition in Biosimilar Market
Teva Pharmaceutical expects the fledgling market for so-called biosimilar drugs to be big, but the cost and complexity of developing them will limit competition, company executives said.
MarketWatch
MarketWatch
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May